Cargando…
Reduction of Depression in Diabetes: A New Pleiotropic Action of Metformin?
Metformin remains the cornerstone of management for type 2 diabetes mellitus (T2DM). It is also known that it has beneficial pleiotropic actions. In addition, there is emerging evidence that this agent may prove beneficial in ameliorating depression in T2DM. The underlying mechanisms of this new act...
Autores principales: | Papachristou, Stella, Papanas, Nikolaos |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Healthcare
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7955898/ https://www.ncbi.nlm.nih.gov/pubmed/33715080 http://dx.doi.org/10.1007/s13300-021-01044-8 |
Ejemplares similares
-
COVID-19 and Diabetes Mellitus: May Old Anti-diabetic Agents Become the New Philosopher’s Stone?
por: Penlioglou, Theano, et al.
Publicado: (2020) -
Skin AGEs and diabetic neuropathy
por: Papachristou, Stella, et al.
Publicado: (2021) -
New-Onset Diabetes in COVID-19: Time to Frame Its Fearful Symmetry
por: Papachristou, Stella, et al.
Publicado: (2020) -
Metformin Beyond Diabetes: Pleiotropic Benefits of Metformin in Attenuation of Atherosclerosis
por: Forouzandeh, Farshad, et al.
Publicado: (2014) -
Diabetic Neuropathy Collection: Progress in Diagnosis and Screening
por: Papanas, Nikolaos
Publicado: (2020)